XOOMAR

ENDRA Life Sciences (NDRA)

ENDRA Life Sciences on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as electromedical & electrotherapeutic apparatus.

Download CSV

24K

Short interest

settlement 2026-10-15

1.4

Days to cover

+0.4 days vs prior

38.4%

Short share of volume

2026-11-02

1,941

Fails to deliver

settlement 2026-09-03

Fri 13 Nov

Next earnings

estimated date

$0

Insider flow, 90 days

0 buys, 0 sells

As of 2026-11-02.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in NDRA is 24,087 shares, down 7,253 shares over the last month. Over the last 48 readings it ranged from 15,787 shares (30 June 2025) to 841,047 shares (31 October 2024). The latest reading sits at the bottom of that range. At the reported average volume of 18K shares a day that is 1.4 days to cover.

Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/ndra" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-10-1524,087-14.7%17,6291.37
2026-09-3028,233-9.9%49,3071.00
2026-09-1531,340-0.9%78,9741.00
2026-08-3131,615+5.1%12,8762.46
2026-08-1430,078-8.7%16,9961.77
2026-07-3132,947+19.2%18,9141.74
2026-07-1527,635-34.4%36,7641.00
2026-06-3042,119+92.3%81,3301.00
2026-06-1521,904+10.5%14,8101.48
2026-05-2919,820-39.2%18,0841.10
2026-05-1532,603-11.8%15,6962.08
2026-04-3036,954-23.5%21,4911.72
2026-04-1548,279-8.4%17,1792.81
2026-03-3152,702-2.2%44,4481.19
2026-03-1353,910-65.2%86,0291.00
2026-02-27154,773+163.6%511,2701.00
2026-02-1358,719+27.0%23,3192.52
2026-01-3046,244-6.3%29,5841.56
2026-01-1549,378-15.3%15,1863.25
2025-12-3158,311-25.3%18,1893.21
2025-12-1578,064-7.3%131,5671.00
2025-11-2884,183-16.1%91,8811.00
2025-11-14100,283+12.7%45,0972.22
2025-10-3189,024-8.2%120,9031.00
2025-10-1596,975-1.6%1,325,1891.00
2025-09-3098,587-6.6%33,0362.98
2025-09-15105,564+2.8%42,0362.51
2025-08-29102,740-19.8%18,8315.46
2025-08-15128,091-1.6%98,2201.30
2025-07-31130,143-44.1%91,1351.43
2025-07-15232,753+1374.3%9,820,9981.00
2025-06-3015,787-6.8%23,6051.00
2025-06-1316,935-67.1%36,4541.00
2025-05-3051,411-23.0%36,7711.40
2025-05-1566,777-45.2%164,1911.00
2025-04-30121,804+172.7%653,4601.00
2025-04-1544,663+41.4%156,4441.00
2025-03-3131,580-22.2%5,9775.28
2025-03-1440,610+43.3%11,5513.52
2025-02-2828,334-9.2%9,1553.09
2025-02-1431,202-6.0%11,1212.81
2025-01-3133,202-15.7%20,9231.59
2025-01-1539,390-24.5%25,2171.56
2024-12-3152,147+15.1%47,6681.09
2024-12-1345,296-32.3%59,6241.00
2024-11-2966,935+7.0%140,9111.00
2024-11-1562,582-92.6%178,4351.00
2024-10-31841,047+17.2%35,610,5881.00

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 2 November 2026, the short share of NDRA volume is 38.4%, up 4.1 points over the last five sessions. Over the last 30 readings it ranged from 5.5% (13 October 2026) to 74.5% (23 October 2026). The latest reading is 2.5 points above the 30-session average of 35.8%, on 2K shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-11-028072K38.4%0
2026-10-308547K12.4%0
2026-10-296K10K58.5%0
2026-10-281K4K40.5%0
2026-10-272K3K49.4%0
2026-10-262K5K34.2%0
2026-10-232K3K74.5%0
2026-10-222K6K29.9%0
2026-10-214K13K32.5%0
2026-10-203K13K24.9%0
2026-10-192K4K39.4%0
2026-10-162K13K17.5%0
2026-10-151K4K36.6%0
2026-10-148747K12.5%0
2026-10-131072K5.5%0
2026-10-128876K15.3%1
2026-10-092K17K14.1%15
2026-10-082K5K30.1%0
2026-10-079763K32.2%0
2026-10-069335K17.1%0
2026-10-058K14K61.0%0
2026-10-026K19K33.4%0
2026-10-016K13K46.5%0
2026-09-304K13K29.1%0
2026-09-295K9K53.0%0
2026-09-283K14K24.3%0
2026-09-254K15K29.3%0
2026-09-2411K18K63.1%0
2026-09-2317K31K54.4%0
2026-09-2220K31K65.1%0

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 3 September 2026, the fails-to-deliver balance in NDRA is 1,941 shares, down 232 shares over the last settlement date. Over the last 30 readings it ranged from 2 shares (2 July 2026) to 3,768 shares (8 April 2026).

SettlementShares failedPriceValue
2026-09-031,941$6.46$13K
2026-07-162,173$5.61$12K
2026-07-152,761$5.54$15K
2026-07-102,780$5.49$15K
2026-07-0673$4.72$345
2026-07-022$5.04$10
2026-06-29771$4.99$4K
2026-06-262,345$4.30$10K
2026-06-252,394$6.19$15K
2026-06-24303$5.31$2K
2026-06-23868$5.18$4K
2026-06-22826$4.76$4K
2026-06-181,666$5.01$8K
2026-06-17782$4.62$4K
2026-06-16850$4.85$4K
2026-06-121,708$4.44$8K
2026-06-058$4.77$38
2026-05-29265$5.52$1K
2026-05-22292$5.35$2K
2026-05-19202$5.41$1K
2026-05-15428$5.90$3K
2026-05-131,096$5.79$6K
2026-04-2839$4.84$189
2026-04-171,110$5.24$6K
2026-04-15562$5.10$3K
2026-04-13582$4.94$3K
2026-04-09111$5.17$574
2026-04-083,768$5.34$20K
2026-04-02848$4.65$4K
2026-03-301,255$4.47$6K

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for NDRA in the last 90 days. The most recent filings are listed below. Latest filing: Tokman Alexander Y (Chief Executive Officer) on 2026-03-02.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-03-02Tokman Alexander YChief Executive OfficerGrant27K$0.00$0102K
2026-03-02Jacroux RichardChief Financial OfficerGrant13K$0.00$033K
2026-01-21Harsh MichaelDirectorGrant60K$0.00$066K
2026-01-21Jacroux RichardChief Financial OfficerGrant20K$0.00$020K
2026-01-21Tokman Alexander YChief Executive OfficerGrant75K$0.00$075K
2026-01-21DIGIANDOMENICO ANTHONYDirectorGrant60K$0.00$0137K
2026-01-21Basenese LouDirectorGrant60K$0.00$066K
2025-10-10DIGIANDOMENICO ANTHONYDirectorGrant71K$7.06$500K76K
2025-06-11Harsh MichaelDirectorGrant5K$0.00$05K
2025-06-11DIGIANDOMENICO ANTHONYDirectorGrant5K$0.00$05K
2025-06-11Basenese LouDirectorGrant5K$0.00$05K
2024-08-27UBS Group AGTenPercentOwnerBuy4K$0.55$2K146K
2024-08-27UBS Group AGOtherBuy0$0.00$0146K
2023-05-18Thornton Michael MilosChief Technology OfficerBuy15K$1.65$25K34K
2023-05-02DIGIANDOMENICO ANTHONYDirectorBuy83K$1.20$100K102K
2022-12-09Thornton Michael MilosChief Technology OfficerBuy2K$3.40$5K19K
2022-11-23Tokman Alexander YDirectorBuy10K$0.17$2K163K
2022-08-22Tokman Alexander YDirectorBuy20K$0.26$5K153K
2022-08-22Thornton Michael MilosChief Technology OfficerBuy20K$0.27$5K353K
2022-05-26Thornton Michael MilosChief Technology OfficerBuy25K$0.21$5K333K
2022-05-18Thornton Michael MilosChief Technology OfficerBuy25K$0.22$6K308K
2022-05-17Michelon Francois RogerChief Executive OfficerBuy5K$0.19$96997K
2022-05-16Tokman Alexander YDirectorBuy100K$0.20$20K133K
2021-08-26Basenese LouDirectorSell5K$1.85$9K49K
2021-08-25Basenese LouDirectorSell45K$1.83$82K54K
2021-04-07Thornton Michael MilosChief Technology OfficerSell15K$2.53$38K260K
2021-03-29Thornton Michael MilosChief Technology OfficerSell19K$2.37$44K275K
2021-02-11Thornton Michael MilosChief Technology OfficerGrant23K$0.00$0317K
2021-01-28Thornton Michael MilosChief Technology OfficerGrant23K$0.00$0317K
2021-01-13Maloberti Renaud BertrandChief Commercial OfficerSell14K$1.10$15K2K
2021-01-12Maloberti Renaud BertrandChief Commercial OfficerSell6K$1.05$7K15K
2021-01-08Tokman Alexander YDirectorSell10K$0.90$9K33K
2021-01-08Maloberti Renaud BertrandChief Commercial OfficerSell9K$0.94$8K22K
2021-01-06Wells David R.Chief Financial OfficerSell35K$0.90$31K80K
2021-01-06Maloberti Renaud BertrandChief Commercial OfficerSell11K$0.94$11K30K
2021-01-05Wells David R.Chief Financial OfficerSell100$0.90$90115K
2020-12-17Maloberti Renaud BertrandChief Commercial OfficerSell25K$0.73$18K42K
2020-12-04Michelon Francois RogerChief Executive OfficerSell72K$0.83$59K92K
2020-11-13Maloberti Renaud BertrandChief Commercial OfficerSell10K$0.81$8K67K
2020-10-01Maloberti Renaud BertrandChief Commercial OfficerSell10K$0.72$7K77K
2020-07-21DIGIANDOMENICO ANTHONYDirectorExercise (in or at the money)101K$0.87$87K382K
2020-07-15Thornton Michael MilosChief Technology OfficerExercise (in or at the money)26K$0.87$23K294K
2020-06-23Michelon Francois RogerChief Executive OfficerExercise (in or at the money)3K$0.87$3K164K
2020-06-23Wells David R.Chief Financial OfficerExercise (in or at the money)5K$0.87$4K115K
2020-06-23Harsh MichaelDirectorExercise (in or at the money)5K$0.87$4K69K
2020-06-08DIGIANDOMENICO ANTHONYDirectorBuy5K$0.92$5K282K
2020-06-08Michelon Francois RogerChief Executive OfficerConversion5K$0.87$5K161K
2020-06-08Thornton Michael MilosChief Technology OfficerConversion52K$0.87$45K268K
2020-06-08Wells David R.Chief Financial OfficerConversion10K$0.87$9K110K
2020-06-08Harsh MichaelDirectorConversion11K$0.87$10K64K
2020-05-29Basenese LouDirectorBuy10K$0.90$9K99K
2020-05-28Basenese LouDirectorBuy10K$0.91$9K89K
2020-05-28DIGIANDOMENICO ANTHONYDirectorBuy5K$0.90$5K277K
2020-05-27Basenese LouDirectorBuy10K$0.85$9K79K
2020-05-26Basenese LouDirectorBuy10K$0.82$8K69K
2020-05-22DIGIANDOMENICO ANTHONYDirectorBuy10K$0.78$8K252K
2020-05-21Basenese LouDirectorBuy10K$0.71$7K59K
2020-04-09Michelon Francois RogerChief Executive OfficerGrant123K$0.00$0156K
2020-04-09Thornton Michael MilosChief Technology OfficerGrant96K$0.00$0216K
2020-04-09Wells David R.Chief Financial OfficerGrant80K$0.00$0100K
2020-04-09Maloberti Renaud BertrandChief Commercial OfficerGrant87K$0.00$087K
2020-04-09DIGIANDOMENICO ANTHONYDirectorGrant43K$0.00$0242K
2020-04-09Harsh MichaelDirectorGrant43K$0.00$053K
2020-04-09Tokman Alexander YDirectorGrant43K$0.00$043K
2020-04-09Gambhir Sanjiv SamDirectorGrant43K$0.00$043K
2020-04-09Basenese LouDirectorGrant42K$0.00$042K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Planned sales (Form 144)

Newest first. JSON

1 Form 144 notice on file for NDRA worth $425K at the prices reported; 0 in the last 90 days worth $0. Latest: Anthony DiGiandomenico filed on 2026-06-25 to sell 70,822 shares ($425K) from 2026-06-26.

FiledSellerSharesMarket valueOf outstandingSale fromBroker
2026-06-25Anthony DiGiandomenicoBoard Member71K$425K5.227%2026-06-26MDB Capital,

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

8 holders report 5% or more of NDRA in their latest filing, 3 on Schedule 13D (active intent). The largest reported stake is LHE LNG Holdings LLC at 15.1% of the class (254,015 shares), filed 2026-10-08 for an event on 2026-10-01.

FiledFormHolderSharesOf classEvent
2026-10-0813DLHE LNG Holdings LLCother entity254K15.1%2026-10-01
2026-10-0813DASP Isotopes Inc.corporation254K15.1%2026-10-01
2026-06-2913D/Ano. 1Anthony DiGiandomenicoindividual197K9.9%2026-06-25
2025-11-1413G/Ano. 2L1 Capital Global Opportunities Master Fund, Ltd.non-US institution36K3.0%2025-11-14
2025-11-1413G/Ano. 1S.H.N. Financial Investments Ltd.non-US institution36K3.0%2025-11-14
2025-10-3013GJohn Carter Lipmanindividual115K10.0%2025-10-23
2025-10-2813GATW Master Fund V LPpartnership116K9.9%2025-10-16
2025-10-2813GATW Partners Opportunities Management, LLCinvestment adviser, other entity116K9.9%2025-10-16
2025-10-2813GKerry Propperparent holding company, individual116K9.9%2025-10-16
2025-10-2813GAntonio Ruiz-Gimenezparent holding company, individual116K9.9%2025-10-16

13F holders

Tracked managers holding NDRA at their latest 13F. JSON

1 of the 30 tracked managers held NDRA at their latest 13F, $159K in total at quarter-end prices. Citadel Advisors is the largest at $159K (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 1 added shares and 0 cut.

FundQuarterSharesValueOf portfolioChange in shares
Citadel Advisors2026-06-3030K$159K0.00%new

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

ENDRA Life Sciences in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows ENDRA Life Sciences (NDRA), SEC CIK 1681682, listed on Nasdaq, classified by the SEC as electromedical & electrotherapeutic apparatus. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest
FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-03.JSON and CSV
Planned sales
SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-06-25.JSON and CSV
Large holders
SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-08.JSON and CSV
13F holders
SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Earnings dates
SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-17.JSON and CSV
Insider trades
SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-03-02.JSON and CSV
Company record
EDGAR filing index for CIK 1681682Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Other companies the SEC classifies as electromedical & electrotherapeutic apparatus

Datasets

Frequently Asked Questions

How much of NDRA is sold short?
24,087 shares were held short at the 2026-10-15 settlement, 1.4 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is NDRA's daily short volume?
On 2026-11-02, 807 of the 2,103 NDRA shares reported to FINRA were sold short, 38.4% of the day's reported volume. Short volume is a flow for one day, not a position.
Does NDRA have fails to deliver?
The SEC's latest file shows 1,941 NDRA shares failed to deliver at settlement 2026-09-03. Fails are reported per settlement date and published twice a month with a lag.
Are NDRA insiders buying or selling?
No open-market insider trades were reported for NDRA in the last 90 days. The most recent filings are listed below. Latest filing: Tokman Alexander Y (Chief Executive Officer) on 2026-03-02.
Have NDRA insiders filed to sell?
1 Form 144 notice on file for NDRA worth $425K at the prices reported; 0 in the last 90 days worth $0. Latest: Anthony DiGiandomenico filed on 2026-06-25 to sell 70,822 shares ($425K) from 2026-06-26.
Who owns 5% or more of NDRA?
8 holders report 5% or more of NDRA in their latest filing, 3 on Schedule 13D (active intent). The largest reported stake is LHE LNG Holdings LLC at 15.1% of the class (254,015 shares), filed 2026-10-08 for an event on 2026-10-01.
Which tracked 13F managers own NDRA?
1 of the 30 tracked 13F managers held NDRA shares at their latest filing, $159K in all. The largest: Ken Griffin's Citadel Advisors (30K shares, $159K).

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.